Jump to main content
Jump to site search

Issue 6, 2013
Previous Article Next Article

Magnetic nanocomplexes and the physiological challenges associated with their use for cancer imaging and therapy

Author affiliations

Abstract

Magnetic nanoparticles offer potential advances in cancer treatment. One example is cancer theranostics, which refers to the combination of a diagnostic tool, i.e., magnetic resonance (MR) imaging, and therapeutic entities such as drugs, oligonucleotides, antibodies, and peptides. They can be conjugated with bioactive molecules and have the ability to form a magnetic field gradient under an external magnetic field. They can offer a variety of active drug delivery and imaging strategies along with modalities such as magnetic hyperthermia. Imaging with magnetic nanoparticles can facilitate more effective cancer therapy through more well informed decision-making. In this article, we review notable progress in magnetic particle design, including surface modifications and multi-functionalization, and we discuss the recent bioapplications of magnetic nanoparticles in simultaneous cancer imaging and therapy.

Graphical abstract: Magnetic nanocomplexes and the physiological challenges associated with their use for cancer imaging and therapy

Back to tab navigation

Article information


Submitted
23 Oct 2012
Accepted
23 Oct 2012
First published
24 Oct 2012

J. Mater. Chem. B, 2013,1, 729-739
Article type
Feature Article

Magnetic nanocomplexes and the physiological challenges associated with their use for cancer imaging and therapy

E. Kim, K. Lee, Y. Huh and S. Haam, J. Mater. Chem. B, 2013, 1, 729
DOI: 10.1039/C2TB00294A

Social activity

Search articles by author

Spotlight

Advertisements